The outlook revision is based on a number of factors, including Summa’s strengthened liquidity, solid market position and improved profitability.
Fitch also assigned an “A-” rating to Summa’s $344 million of series 2016 bonds.
More articles on healthcare finance:
This week’s 5 must-reads for hospital CFOs
This week’s 5 must-reads for hospital RCM leaders
Medical bills less burdensome for millions of Americans: 5 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
